DVA DaVita Inc. Common Stock
NYSE · Health Care · Ver en SEC EDGAR ↗ cerrar Oct 2, 2026 10-K/10-Q Ago 4, 2026DVA Instantánea de la Acción Precio, capitalización bursátil, P/E, BPA, ROE, deuda/capital, rango de 52 semanas
DVA Gráfico del Precio de la Acción OHLCV diario con indicadores técnicos — desplace, amplíe y personalice su vista
La granularidad de las barras se adapta al período seleccionado; pase el ratón sobre el gráfico para ver la apertura/máximo/mínimo/cierre de una barra.
| Fecha ex-dividendo | División | Tipo |
|---|---|---|
| 9 de septiembre de 2013 | 2-for-1 | Adelante |
| 16 de junio de 2004 | 3-for-2 | Adelante |
| 21 de octubre de 1997 | 5-for-3 | Adelante |
Acerca de DaVita Inc. Common Stock Descripción general de la empresa de Wikipedia
DaVita Inc. (a shortened contraction of "dare vita, meaning "to give life" in the Italian language) is an American health care company, incorporated in Delaware and headquartered in Denver, that provides kidney dialysis services through a network of 2,657 outpatient centers in the United States. DaVita serves 200,500 patients (36% of the total of 557,000 patients in the U.S.), and has 585 outpatient centers in 14 other countries serving 94,500 patients. The company primarily treats end-stage renal disease (ESRD), which requires patients to undergo kidney dialysis, often 3 times per week for the rest of their lives unless they receive a kidney transplant via organ donation.
In 2025, 68% of the company's revenues came from Medicare and other government-based health insurance programs. In 2025, 89% of the company's patients were covered by government-based health insurance programs. Commercial payers, which accounted for 32% of revenues in 2025, generate nearly all of the company's profit as they reimburse at a much higher rate than government-based health insurance programs. The company is ranked 331st on the 2026 Fortune 500.
## History
The company was founded in 1979 as Medical Ambulatory Care, Inc., a subsidiary of National Medical Enterprises, Inc. (now Tenet Healthcare).
In August 1994, 70% of the company was acquired by DLJ Merchant Banking Partners in a leveraged buyout for $75.5 million, including a $10.5 million investment by DLJ. The company then changed its name to Total Renal Care Holdings, Inc. In October 1995, the company became a public company via an initial public offering, raising $107 million. By December 1996, DLJ had made a 386% return on its $10.5 million investment.
On February 27, 1998, the company acquired Renal Treatment Centers for $1.3 billion in stock. The integration went poorly and in July 1999, the CEO and CFO resigned. After tripling in value between 1995 and 1998, by July 1999, the stock price was down 71% year-to-date. In October 1999, Kent J. Thiry, then 43 years old, was named CEO.
In 2000, the company sold its non-U.S. operations. In October 2000, the company was renamed DaVita Inc. In October 2005, the company acquired Gambro Healthcare. In 2012, DaVita acquired Healthcare Partners for $4.42 billion, which was renamed DaVita Medical Group. In June 2019, the division was sold to UnitedHealth Group for $4.3 billion. In 2014, DaVita acquired Colorado Springs Health Partners, with 600 employees and 110,000 patients. In March 2016, it acquired the Everett Clinic Medical Group, a 20-site physicians practice with 315,000 patients in the Seattle area, for $385 million. In May 2017, it acquired WellHealth Quality Care.
In October 2014, the company agreed to pay $350 million to settle claims that it provided illegal kickbacks to doctors. In June 2015, the company agreed to pay $450 million to settle allegations that it unnecessarily disposed of drugs and then billed the U.S. federal government for this waste. In June 2018, a jury awarded the families of 3 of the company's patients $383 million in wrongful death claims after the patients died from cardiac arrest after undergoing treatment at DaVita centers. In October 2018, it agreed to pay $270 million to settle allegations that it violated the False Claims Act by providing inaccurate information that caused Medicare Advantage Plans to receive inflated payments. James Swoben, a whistleblower, received $10 million.
In July 2021, a federal grand jury indicted DaVita and former CEO Kent Thiry on charges of labor market collusion alleging participation in conspiracies with Surgical Care Affiliates to suppress competition for the services of certain senior-level employees. The company and Thiry were acquitted by a jury in April 2022. In October 2021, the Federal Trade Commission imposed limits on the company engaging in more mergers in Utah because of its history of buying up competitors.
In 2024, the Federal Trade Commission began investigating Davita along with Fresenius Medical Care under allegations they use illegal tactics to push smaller companies out of the market. In May 2025, the benefits fund of the United Food and Commercial Workers Local 1776 filed a proposed class-action lawsuit against DaVita and Fresenius Medical Care, a rival dialysis provider, alleging that the two companies illegally conspired to inflate treatment costs.
Fuente: Wikipedia (Inglés), CC BY-SA 4.0 · Ver en Wikipedia ↗
Rendimiento a 10 años Tendencias de ingresos, beneficio neto, márgenes y BPA
Valoración Ratios P/E, P/S, P/B, EV/EBITDA: ¿está la acción cara o barata?
| Métrica | Tendencia a 5 años | DVA | promedio 5A | Mediana de Pares | Veredicto |
|---|---|---|---|---|---|
| P/E (TTM) | 14.7promedio 5A ≈13.0 | ≈13.0 | 23.4 | Infravalorado | |
| P/S (TTM) | 0.8promedio 5A ≈0.8 | ≈0.8 | 1.8 | Infravalorado | |
| P/C (MRQ) | -14.9promedio 5A ≈24.1 | ≈24.1 | · | · | |
| Precio / FCF (TTM) | 7.1promedio 5A ≈7.2 | ≈7.2 | · | · | |
| Precio / Flujo de Caja (TTM) | 5.2promedio 5A ≈4.9 | ≈4.9 | 11.3 | Infravalorado | |
| Precio / Valor Contable Tangible (MRQ) | -11.5 | · | · | · | |
| PEG Ratio (Ratio PEG) | ≈1.6 | · | · | · |
La mediana de empresas comparables se calcula sobre una base estandarizada por métrica y puede no coincidir siempre con la base TTM/MRQ que se muestra para esta acción.
Rentabilidad Márgenes brutos, operativos y netos; ROE, ROA, ROIC
| Métrica | Tendencia a 5 años | DVA | promedio 5A | Mediana de Pares | Veredicto |
|---|---|---|---|---|---|
| Margen Operativo (TTM) | 15.2%promedio 5A ≈14.3% | ≈14.3% | 9.2% | De primer nivel | |
| Margen EBITDA (TTM) | 20.2%promedio 5A ≈20.1% | ≈20.1% | 12.7% | De primer nivel | |
| Margen antes de impuestos (TTM) | 10.5%promedio 5A ≈10.6% | ≈10.6% | 4.3% | De primer nivel | |
| Margen de Beneficio Neto (TTM) | 6.0%promedio 5A ≈6.3% | ≈6.3% | 5.1% | De primer nivel | |
| ROA (TTM) | 4.8%promedio 5A ≈4.6% | ≈4.6% | 3.7% | De primer nivel | |
| ROE (TTM) | -149.4%promedio 5A ≈24.7% | ≈24.7% | 10.5% | Débil | |
| ROIC | -245.6%promedio 5A ≈325.5% | ≈325.5% | 5.1% | Débil |
Salud financiera Deuda, liquidez, solvencia — solidez del balance general
| Métrica | Tendencia a 5 años | DVA | promedio 5A | Mediana de Pares | Veredicto |
|---|---|---|---|---|---|
| Ratio corriente (MRQ) | 1.5promedio 5A ≈1.3 | ≈1.3 | 1.5 | En línea | |
| Ratio Rápido (MRQ) | 1.1promedio 5A ≈1.0 | ≈1.0 | 1.0 | En línea |
Crecimiento Crecimiento de ingresos, BPA y beneficio neto: interanual, CAGR a 3 años, CAGR a 5 años
| Métrica | Tendencia a 5 años | DVA | promedio 5A | Mediana de Pares | Veredicto |
|---|---|---|---|---|---|
| Revenue YoY (Ingresos interanuales) | 6.5%promedio 5A ≈3.4% | ≈3.4% | · | · | |
| Revenue CAGR 3Y (Ingresos CAGR 3A) | 5.5%promedio 5A ≈3.5% | ≈3.5% | · | · | |
| Revenue CAGR 5Y (Ingresos CAGR 5A) | 3.4% | · | · | · | |
| EPS YoY (EPS interanual) | -8.3%promedio 5A ≈14.0% | ≈14.0% | · | · | |
| Net Income YoY (Beneficio Neto interanual) | -20.2%promedio 5A ≈4.5% | ≈4.5% | · | · | |
| EPS CAGR 3Y (CAGR BPA 3A) | 18.9%promedio 5A ≈10.3% | ≈10.3% | · | · | |
| EPS CAGR 5Y (CAGR BPA 5A) | 9.3% | · | · | · | |
| Net Income CAGR 3Y (CAGR Beneficio Neto 3A) | 10.0%promedio 5A ≈1.6% | ≈1.6% | · | · | |
| Net Income CAGR 5Y (CAGR Beneficio Neto 5A) | -0.70% | · | · | · |
Eficiencia de capital Rotación de activos, rotación de inventario, rotación de cuentas por cobrar
| Métrica | Tendencia a 5 años | DVA | promedio 5A | Mediana de Pares | Veredicto |
|---|---|---|---|---|---|
| Asset Turnover (Rotación de Activos) | 0.8promedio 5A ≈0.7 | ≈0.7 | 0.8 | En línea | |
| Receivables Turnover (Rotación de Cuentas por Cobrar) | 6.0promedio 5A ≈6.0 | ≈6.0 | 10.6 | Débil | |
| Revenue / Employee (Ingresos / Empleado) | ≈$174.9K | · | · | · |
valor · ≈ promedio 5A · mediana sectorial · veredicto relativo a la mediana
Dividendos Rendimiento, ratio de pago, historial de dividendos, CAGR a 5 años
Historial de Ganancias EPS real vs estimado, sorpresa %, tasa de aciertos, próxima fecha de resultados
| Período | Informe | EPS Actual | EPS est. | Sorpresa |
|---|---|---|---|---|
| 30 de junio de 2026 | Ago 3, 2026 | $4.02 | $3.92 | 2.5% |
| 31 de marzo de 2026 | May 11, 2026 | $2.87 | $2.34 | 22.6% |
| 31 de diciembre de 2025 | $3.40 | $3.19 | 6.7% | |
| 30 de septiembre de 2025 | $2.04 | $3.25 | -37.3% | |
| 30 de junio de 2025 | $2.95 | $2.83 | 4.2% | |
| 31 de marzo de 2025 | $2.00 | $1.97 | 1.7% |
Fundamentales Completos Todas las métricas por año — estado de resultados, balance general, flujo de caja
Estado de resultados
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $13.64B | $12.82B | $12.14B | $11.61B | $11.62B | $11.55B | $11.39B | $11.40B | $10.88B | $10.71B | |
| SG&A Expense | $1.67B | $1.54B | $1.47B | $1.36B | $1.20B | $1.25B | $1.10B | $1.14B | $1.06B | $1.07B | |
| Operating Expenses | $11.60B | $10.73B | $10.54B | $10.27B | $9.82B | $9.86B | $9.75B | $9.88B | $9.06B | $8.68B | |
| Operating Income | $2.04B | $2.09B | $1.60B | $1.34B | $1.80B | $1.69B | $1.64B | $1.53B | $1.81B | $2.03B | |
| Other Non-op | $-103M | $-70M | $-19M | $-16M | $6M | $17M | $29M | $10M | $18M | $8M | |
| Pretax Income | $1.35B | $1.53B | $1.18B | $966M | $1.52B | $1.32B | $1.20B | $1.05B | $1.40B | $1.62B | |
| Income Tax | $293M | $280M | $220M | $198M | $307M | $314M | $280M | $258M | $324M | $432M | |
| Net Income | $747M | $936M | $692M | $560M | $978M | $774M | $811M | $159M | $664M | $880M | |
| EPS (Basic) | $10.06 | $11.02 | $7.62 | $6.03 | $9.30 | $6.46 | $5.29 | $0.93 | $3.52 | $4.36 | |
| EPS (Diluted) | $9.84 | $10.73 | $7.42 | $5.85 | $8.90 | $6.31 | $5.27 | $0.92 | $3.47 | $4.29 | |
| Shares (Basic) | 74,227,000 | 84,991,000 | 90,790,000 | 92,992,000 | 105,230,000 | 119,797,000 | 153,181,000 | 170,786,000 | 188,625,559 | 201,641,173 | |
| Shares (Diluted) | 75,885,000 | 87,274,000 | 93,182,000 | 95,834,000 | 109,948,000 | 122,623,000 | 153,812,000 | 172,365,000 | 191,348,533 | 204,904,656 | |
| EBITDA | $2.75B | $2.81B | $2.34B | $2.06B | $2.47B | $2.31B | $2.24B | $2.10B | $2.36B | $2.44B |
Balance general
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $676M | $795M | $380M | $244M | $462M | $325M | $1.10B | $323M | $508M | $675M | |
| Short-term Investments | $24M | $51M | $12M | $78M | $22M | $20M | $12M | $3M | $33M | $307M | |
| Receivables | $2.41B | $2.15B | $1.99B | $2.13B | $1.96B | $1.82B | $1.80B | $1.86B | $1.71B | $1.50B | |
| Inventory | $161M | $135M | $143M | $109M | $107M | $112M | $98M | $107M | $182M | $160M | |
| Prepaid Expense | $156M | $123M | $103M | $79M | $73M | $76M | $67M | $112M | $112M | $100M | |
| Other Current Assets | · | · | · | · | · | · | · | · | $112M | $100M | |
| Current Assets | $4.06B | $3.75B | $3.14B | $3.16B | $3.17B | $3.15B | $3.69B | $8.42B | $8.77B | $3.99B | |
| PP&E (Net) | $2.81B | $2.94B | $3.07B | $3.26B | $3.48B | $3.52B | $3.47B | $3.39B | $3.15B | $2.86B | |
| PP&E (Gross) | $9.42B | $9.20B | $8.83B | $8.52B | $8.24B | $8.00B | $7.44B | $6.92B | $6.25B | $5.56B | |
| Accum. Depreciation | $6.60B | $6.26B | $5.76B | $5.27B | $4.76B | $4.48B | $3.97B | $3.52B | $3.10B | $2.70B | |
| Goodwill | $7.55B | $7.38B | $7.11B | $7.08B | $7.05B | $6.92B | $6.79B | $6.84B | $6.61B | $6.02B | |
| Intangibles | $222M | $197M | $203M | $183M | $178M | $167M | $136M | $119M | $114M | $74M | |
| Other Non-current Assets | $247M | $262M | $271M | $316M | $137M | $80M | $116M | $72M | $47M | $34M | |
| Total Assets | $17.48B | $17.29B | $16.89B | $16.93B | $17.12B | $16.99B | $17.31B | $19.11B | $18.97B | $18.76B | |
| Accounts Payable | $696M | $547M | $515M | $480M | $402M | $434M | $404M | $463M | $509M | $457M | |
| Current Liabilities | $3.14B | $2.97B | $2.64B | $2.62B | $2.40B | $2.48B | $2.37B | $4.89B | $3.07B | $2.71B | |
| Capital Leases | $2.18B | $2.21B | $2.33B | $2.50B | $2.67B | $2.74B | $2.72B | $0 | · | · | |
| Deferred Tax | $757M | $665M | $726M | $783M | $831M | $810M | $578M | $563M | $486M | $531M | |
| Other Non-current Liabilities | $84M | $170M | $183M | $105M | $119M | $150M | $161M | $451M | $365M | $317M | |
| Total Liabilities | $16.32B | $15.19B | $14.15B | $14.70B | $14.75B | $14.09B | $13.81B | $14.08B | $13.08B | $12.93B | |
| Common Stock | $69.0K | $90.0K | $89.0K | $90.0K | $97.0K | $110.0K | $126.0K | $166.0K | $182.0K | $195.0K | |
| Retained Earnings | $-328M | $1.53B | $598M | $174M | $354M | $853M | $1.43B | $2.74B | $3.63B | $3.71B | |
| Treasury Stock | $200M | $1.39B | $0 | · | $0 | $0 | $0 | $0 | $0 | $0 | |
| AOCI | $-123M | $-311M | $-52M | $-69M | $-139M | $-66M | $-47M | $-35M | $13M | $-90M | |
| Stockholders' Equity | $-651M | $121M | $1.06B | $712M | $756M | $1.38B | $2.13B | $3.70B | $4.69B | $4.65B | |
| Liabilities + Equity | $17.48B | $17.29B | $16.89B | $16.93B | $17.12B | $16.99B | $17.31B | $19.11B | $18.97B | $18.76B | |
| Shares Outstanding | 68,549,000 | 90,369,000 | 88,824,000 | 90,411,000 | 97,289,000 | 109,933,000 | 125,843,000 | 166,387,000 | 182,462,000 | 194,554,000 |
Flujo de Efectivo
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $708M | $716M | $736M | $721M | $668M | $617M | $601M | $575M | $544M | $495M | |
| Stock-based Comp | $140M | $103M | $112M | $95M | $102M | $91M | $68M | $73M | $35M | $38M | |
| Deferred Tax | $87M | $-58M | $-39M | $-76M | $60M | $241M | $42M | $274M | $-395M | $52M | |
| Amort. of Intangibles | $7M | $7M | $9M | $11M | $13M | $14M | $14M | $16M | $16M | $15M | |
| Other Non-cash | $205M | $324M | $558M | $263M | $122M | $256M | $551M | $691M | $1.06B | $447M | |
| Operating Cash Flow | $1.89B | $2.02B | $2.06B | $1.56B | $1.93B | $1.98B | $2.07B | $1.77B | $1.91B | $1.97B | |
| CapEx | $576M | $555M | $568M | $603M | $641M | $675M | $767M | $987M | $905M | $829M | |
| Investing Cash Flow | $-655M | $-771M | $-772M | $-630M | $-785M | $-825M | $3.00B | $-1.01B | $-1.36B | $-1.20B | |
| Debt Issued | $5.61B | $6.62B | $2.47B | $2.39B | $1.62B | $4.05B | $38.53B | $59.93B | $50.99B | $51.99B | |
| Net Debt Issued | $5.61B | $6.62B | $2.47B | $2.39B | $1.62B | $4.05B | $38.53B | $59.93B | $50.99B | $51.99B | |
| Stock Repurchased | $1.31B | $1.39B | $272M | $802M | $1.54B | $1.46B | $2.38B | $1.16B | $803M | $1.10B | |
| Net Stock Activity | $-1.31B | $-1.39B | $-272M | $-802M | $-1.54B | $-1.46B | $-2.38B | $-1.16B | $-803M | $-1.10B | |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | · | · | |
| Financing Cash Flow | $-1.37B | $-817M | $-1.17B | $-1.12B | $-1.08B | $-1.85B | $-4.70B | $-625M | $-766M | $-1.35B | |
| Net Change in Cash | $-122M | $415M | $126M | $-216M | $53M | $-707M | $369M | $137M | $-218M | $-577M | |
| Taxes Paid | $177M | $388M | $268M | · | · | · | · | · | · | · | |
| Free Cash Flow | $1.31B | $1.47B | $1.49B | $961M | $1.29B | $1.30B | $1.31B | $785M | $1.00B | $1.13B |
Rentabilidad
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | 15.0% | 16.3% | 13.2% | 11.5% | 15.5% | 14.7% | 14.4% | 13.4% | · | · | |
| Net Margin | 5.5% | 7.3% | 5.7% | 4.8% | 8.4% | 6.7% | 7.1% | 1.4% | · | · | |
| Pretax Margin | 9.9% | 11.9% | 9.7% | 8.3% | 13.1% | 11.4% | 10.5% | 9.2% | · | · | |
| EBITDA Margin | 20.2% | 21.9% | 19.3% | 17.8% | 21.2% | 20.0% | 19.7% | 18.4% | · | · | |
| ROA | 4.3% | 5.5% | 4.1% | 3.3% | 5.7% | 4.5% | 4.5% | 0.84% | 3.5% | 4.7% | |
| ROE | -281.8% | 159.1% | 78.2% | 76.4% | 91.5% | 44.0% | 27.8% | 3.8% | 14.2% | 18.5% | |
| ROIC | -245.6% | 1410.5% | 123.4% | 149.4% | 189.8% | 93.3% | 59.0% | 31.1% | 29.7% | 28.3% |
Liquidez y Solvencia
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.3 | 1.3 | 1.2 | 1.2 | 1.3 | 1.3 | 1.6 | 1.7 | 2.9 | 1.5 | |
| Quick Ratio | 1.0 | 1.0 | 0.9 | 0.9 | 1.0 | 0.9 | 1.2 | 0.4 | 0.7 | 1.2 |
Eficiencia
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.8 | 0.7 | 0.7 | 0.7 | 0.7 | 0.7 | 0.6 | 0.6 | · | · | |
| Receivables Turnover | 6.0 | 6.2 | 5.9 | 5.7 | 6.1 | 6.4 | 6.2 | 6.4 | · | · |
Por Acción
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $-9.50 | $1.50 | $11.89 | $7.88 | $7.77 | $12.59 | $16.95 | $22.26 | $25.70 | $23.89 | |
| Revenue / Share | $179.79 | $146.84 | $130.28 | $121.15 | $105.68 | $94.20 | $74.04 | $66.17 | · | · | |
| Cash Flow / Share | $24.86 | $23.17 | $22.10 | $16.33 | $17.56 | $16.14 | $13.47 | $10.28 | $9.97 | $9.58 | |
| Cash / Share | $9.87 | $9.87 | $4.28 | $2.70 | $4.75 | $2.96 | $8.76 | $1.94 | $2.79 | $4.69 | |
| EPS (TTM) | $9.84 | $10.73 | $7.42 | $5.85 | $8.90 | $6.31 | $5.27 | $0.92 | $3.47 | $4.29 |
Tasas de Crecimiento
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 6.5% | 5.6% | 4.6% | -0.08% | 0.59% | · | · | · | · | · | |
| Revenue CAGR 3Y | 5.5% | 3.3% | 1.7% | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 3.4% | · | · | · | · | · | · | · | · | · | |
| EPS YoY | -8.3% | 44.6% | 26.8% | -34.3% | 41.0% | · | · | · | · | · | |
| EPS CAGR 3Y | 18.9% | 6.4% | 5.5% | · | · | · | · | · | · | · | |
| EPS CAGR 5Y | 9.3% | · | · | · | · | · | · | · | · | · | |
| Net Income YoY | -20.2% | 35.4% | 23.4% | -42.7% | 26.5% | · | · | · | · | · | |
| Net Income CAGR 3Y | 10.0% | -1.5% | -3.7% | · | · | · | · | · | · | · | |
| Net Income CAGR 5Y | -0.70% | · | · | · | · | · | · | · | · | · |
Valoración (TTM)
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $13.64B | $12.82B | $12.14B | $11.61B | $11.62B | $11.55B | $11.39B | $11.40B | $10.88B | $10.71B | |
| Net Income TTM | $747M | $936M | $692M | $560M | $978M | $774M | $811M | $159M | $664M | $880M | |
| Market Cap | $7.79B | $12.04B | $9.31B | $6.75B | $11.07B | $12.91B | $9.44B | $8.56B | $13.18B | $12.49B | |
| P/E | 11.5 | 13.9 | 14.1 | 12.8 | 12.8 | 18.6 | 14.2 | 55.9 | 20.8 | 15.0 | |
| P/S | 0.6 | 0.9 | 0.8 | 0.6 | 1.0 | 1.1 | 0.8 | 0.8 | 1.2 | 1.2 | |
| P/B | -12.0 | 99.4 | 8.8 | 9.5 | 14.6 | 9.3 | 4.4 | 2.3 | 2.8 | 2.7 | |
| P / Cash Flow | 4.1 | 6.0 | 4.5 | 4.3 | 5.7 | 6.5 | 4.6 | 4.8 | 6.9 | 6.4 | |
| P / FCF | 5.9 | 8.2 | 6.2 | 7.0 | 8.6 | 9.9 | 7.2 | 10.9 | 13.2 | 11.0 | |
| Dividend Yield | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | · | · | |
| Earnings Yield | 8.7% | 7.2% | 7.1% | 7.8% | 7.8% | 5.4% | 7.0% | 1.8% | 4.8% | 6.7% | |
| Payout Ratio | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | · | · | · | |
| Annual Payout | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | · | · |
Estado de resultados
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $3.55B | $3.42B | $3.62B | $3.42B | $3.38B | $3.22B | $3.29B | $3.26B | $3.19B | $3.07B | $3.15B | $3.12B | $3.00B | $2.87B | $2.92B | $2.95B | |
| SG&A Expense | $423M | $422M | $472M | $414M | $413M | $374M | $414M | $394M | $368M | $362M | $401M | $377M | $364M | $332M | $380M | $365M | |
| Operating Expenses | $2.98B | $2.93B | $3.06B | $2.91B | $2.84B | $2.78B | $2.73B | $2.73B | $2.68B | $2.59B | $2.76B | $2.63B | $2.60B | $2.56B | $2.66B | $2.64B | |
| Operating Income | $579M | $482M | $561M | $506M | $538M | $439M | $565M | $535M | $506M | $484M | $390M | $496M | $405M | $312M | $256M | $312M | |
| Other Non-op | $8M | $4M | $-21M | $-41M | $-23M | $-18M | $-13M | $-17M | $-27M | $-13M | $-5M | $-20M | $1M | $4M | $-8M | $-5M | |
| Pretax Income | $435M | $341M | $383M | $309M | $369M | $286M | $414M | $373M | $371M | $372M | $289M | $378M | $295M | $215M | $147M | $207M | |
| Income Tax | $92M | $66M | $77M | $69M | $94M | $54M | $64M | $78M | $72M | $66M | $58M | $69M | $49M | $44M | $34M | $43M | |
| Net Income | $265M | $198M | $234M | $150M | $199M | $163M | $259M | $215M | $223M | $240M | $151M | $247M | $179M | $116M | $68M | $105M | |
| EPS (Basic) | $4.10 | $2.93 | $3.30 | $2.09 | $2.62 | $2.05 | $3.17 | $2.56 | $2.56 | $2.73 | $1.68 | $2.70 | $1.96 | $1.28 | $0.81 | $1.16 | |
| EPS (Diluted) | $4.02 | $2.87 | $3.22 | $2.04 | $2.58 | $2.00 | $3.08 | $2.50 | $2.50 | $2.65 | $1.64 | $2.62 | $1.91 | $1.25 | $0.81 | $1.13 | |
| Shares (Basic) | 64,781,000 | 67,390,000 | · | 72,075,000 | 75,943,000 | 79,368,000 | · | 83,721,000 | 86,899,000 | 87,775,000 | · | 91,322,000 | 90,984,000 | 90,497,000 | · | 91,160,000 | |
| Shares (Diluted) | 66,092,000 | 68,875,000 | · | 73,769,000 | 77,362,000 | 81,275,000 | · | 85,795,000 | 88,950,000 | 90,547,000 | · | 94,041,000 | 93,418,000 | 92,483,000 | · | 93,263,000 | |
| EBITDA | $579M | $660M | · | $506M | $538M | $615M | · | $535M | $506M | $671M | · | $496M | $405M | $490M | · | $312M |
Balance general
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $669M | $644M | $676M | $706M | $708M | $439M | $795M | $1.07B | $416M | $345M | · | $449M | $327M | $317M | · | $368M | |
| Short-term Investments | $20M | $22M | $24M | $31M | $31M | $73M | $51M | $21M | $21M | $11M | · | $12M | $12M | $50M | · | $74M | |
| Receivables | $2.47B | $2.46B | $2.41B | $2.33B | $2.44B | $2.32B | $2.15B | $2.27B | $2.30B | $2.59B | · | $2.02B | $2.01B | $2.06B | · | $2.09B | |
| Inventory | $152M | $142M | $161M | $139M | $146M | $151M | $135M | $129M | $127M | $146M | · | $110M | $110M | $107M | · | $107M | |
| Prepaid Expense | $149M | $160M | $156M | $161M | $110M | $130M | $123M | $97M | $83M | $105M | · | $91M | $90M | $89M | · | $66M | |
| Current Assets | $4.19B | $4.06B | $4.06B | $4.11B | $4.09B | $3.64B | $3.75B | $4.04B | $3.47B | $3.68B | · | $3.14B | $3.00B | $3.04B | · | $3.20B | |
| PP&E (Net) | $2.75B | $2.75B | $2.81B | $2.85B | $2.85B | $2.90B | $2.94B | $2.94B | $2.98B | $3.03B | · | $3.10B | $3.16B | $3.22B | · | $3.24B | |
| PP&E (Gross) | · | · | $9.42B | · | · | · | $9.20B | · | · | · | · | · | · | · | · | · | |
| Accum. Depreciation | $6.87B | · | $6.60B | · | · | · | $6.26B | · | · | · | · | · | · | · | · | · | |
| Goodwill | $7.59B | $7.58B | $7.55B | $7.54B | $7.47B | $7.42B | $7.38B | $7.23B | $7.20B | $7.23B | $7.11B | $7.09B | $7.11B | $7.09B | $7.08B | $7.02B | |
| Intangibles | $229M | $229M | $222M | $220M | $212M | $205M | $197M | $198M | $191M | $201M | · | $185M | $192M | $187M | · | $180M | |
| Other Non-current Assets | $299M | $267M | $247M | $204M | $193M | $239M | $262M | $219M | $240M | $262M | · | $302M | $314M | $291M | · | $308M | |
| Total Assets | $17.71B | $17.50B | $17.48B | $17.56B | $17.49B | $17.12B | $17.29B | $17.50B | $17.03B | $17.43B | · | $16.93B | $16.96B | $16.73B | · | $16.96B | |
| Accounts Payable | $716M | $691M | $696M | $656M | $594M | $596M | $547M | $488M | $494M | $490M | · | $435M | $428M | $448M | · | $417M | |
| Current Liabilities | $2.86B | $2.87B | $3.14B | $3.02B | $2.93B | $2.91B | $2.97B | $2.94B | $2.99B | $2.58B | · | $2.54B | $2.40B | $2.57B | · | $2.54B | |
| Capital Leases | $2.19B | $2.16B | $2.18B | $2.10B | $2.12B | $2.16B | $2.21B | $2.24B | $2.28B | $2.31B | · | $2.34B | $2.38B | $2.46B | · | $2.56B | |
| Deferred Tax | $826M | $819M | $757M | $742M | $646M | $665M | $665M | $660M | $694M | $720M | · | $754M | $760M | $771M | · | $819M | |
| Other Non-current Liabilities | $99M | $89M | $84M | $172M | $156M | $167M | $170M | $183M | $179M | $180M | · | $185M | $183M | $100M | · | $107M | |
| Total Liabilities | $16.63B | $16.45B | $16.32B | $16.22B | $15.94B | $15.46B | $15.19B | $15.28B | $14.60B | $14.79B | · | $14.10B | $14.33B | $14.31B | · | $14.89B | |
| Common Stock | $69.0K | $69.0K | $69.0K | $91.0K | $91.0K | $91.0K | $90.0K | $90.0K | $90.0K | $90.0K | · | $91.0K | $91.0K | $91.0K | · | $98.0K | |
| Retained Earnings | $81M | $-179M | $-328M | $2.05B | $1.90B | $1.70B | $1.53B | $1.28B | $1.06B | $838M | · | $715M | $469M | $290M | · | $847M | |
| Treasury Stock | $788M | $489M | $200M | $2.90B | $2.49B | $2.04B | $1.39B | $1.02B | $616M | $240M | · | · | · | · | · | $788M | |
| AOCI | $-59M | $-87M | $-123M | $-116M | $-138M | $-227M | $-311M | $-162M | $-195M | $-100M | · | $-69M | $-7M | $-55M | · | $-136M | |
| Stockholders' Equity | $-765M | $-755M | $-651M | $-572M | $-370M | $-267M | $121M | $387M | $633M | $926M | · | $1.20B | $1.02B | $825M | · | $533M | |
| Liabilities + Equity | $17.71B | $17.50B | $17.48B | $17.56B | $17.49B | $17.12B | $17.29B | $17.50B | $17.03B | $17.43B | · | $16.93B | $16.96B | $16.73B | · | $16.96B | |
| Shares Outstanding | 63,955,000 | 69,190,000 | 68,549,000 | 70,977,000 | 74,217,000 | 77,277,000 | 80,536,000 | 82,624,000 | 85,081,000 | 89,822,000 | 88,824,000 | 91,348,000 | 91,271,000 | 90,650,000 | 90,411,000 | 90,104,000 |
Flujo de Efectivo
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $168M | $178M | $180M | $177M | $175M | $176M | $167M | $187M | $176M | $187M | $186M | $188M | $184M | $178M | $183M | $194M | |
| Stock-based Comp | $26M | $28M | $38M | $39M | $33M | $30M | $27M | $27M | $24M | $25M | $30M | $27M | $30M | $25M | $18M | $28M | |
| Deferred Tax | $-1M | $55M | $18M | $79M | $-14M | $4M | $-4M | $-25M | $-25M | $-3M | $-22M | $-2M | $-13M | $-4M | $-40M | $-45M | |
| Other Non-cash | · | $-137M | · | · | · | $-193M | · | · | · | $-583M | · | · | · | $147M | · | · | |
| Operating Cash Flow | $490M | $321M | $541M | $842M | $324M | $180M | $548M | $810M | $799M | $-135M | $485M | $661M | $450M | $463M | $344M | $711M | |
| CapEx | $170M | $102M | $145M | $166M | $121M | $143M | $171M | $139M | $125M | $121M | $159M | $137M | $124M | $148M | $194M | $144M | |
| Investing Cash Flow | $-194M | $-139M | $-163M | $-263M | $-67M | $-162M | $-248M | $-146M | $-162M | $-215M | $-168M | $-140M | $-347M | $-117M | $-213M | $-154M | |
| Debt Issued | $1.51B | $1.26B | $940M | $482M | $3.56B | $633M | $676.0K | $3.35B | $1.99B | $1.29B | $6.0K | $331M | $1.53B | $612M | $687M | $523M | |
| Net Debt Issued | · | $1.26B | · | · | · | $633M | · | · | · | $1.29B | · | · | · | $612M | · | · | |
| Stock Repurchased | $181M | $196M | $274M | $240M | $284M | $510M | $365M | $408M | $362M | $251M | $272M | $0 | $0 | $0 | $0 | $185M | |
| Net Stock Activity | · | $-196M | · | · | · | $-510M | · | · | · | $-251M | · | · | · | $0 | · | · | |
| Financing Cash Flow | $-270M | $-213M | $-415M | $-582M | $4M | $-383M | $-565M | $-8M | $-563M | $319M | $-403M | $-395M | $-97M | $-276M | $-231M | $-445M | |
| Net Change in Cash | $25M | $-31M | $-38M | $-2M | $272M | $-355M | $-279M | $655M | $72M | $-34M | $-80M | $123M | $11M | $72M | $-123M | $106M | |
| Free Cash Flow | · | $219M | · | · | · | $37M | · | · | · | $-256M | · | · | · | $315M | · | · |
Rentabilidad
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | 16.3% | 14.1% | · | 14.8% | 15.9% | 13.6% | · | 16.4% | 15.9% | 15.8% | · | 15.9% | 13.5% | 10.8% | · | 10.6% | |
| Net Margin | 7.5% | 5.8% | · | 4.4% | 5.9% | 5.1% | · | 6.6% | 7.0% | 7.8% | · | 7.9% | 6.0% | 4.0% | · | 3.6% | |
| Pretax Margin | 12.2% | 10.0% | · | 9.0% | 10.9% | 8.9% | · | 11.4% | 11.7% | 12.1% | · | 12.1% | 9.8% | 7.5% | · | 7.0% | |
| EBITDA Margin | 16.3% | 19.3% | · | 14.8% | 15.9% | 19.1% | · | 16.4% | 15.9% | 21.9% | · | 15.9% | 13.5% | 17.1% | · | 10.6% | |
| ROA | 1.5% | 1.1% | · | 0.86% | 1.1% | 0.94% | · | 1.2% | 1.3% | 1.4% | · | 1.5% | 1.1% | 0.68% | · | 0.61% | |
| ROE | -46.8% | -38.6% | · | -162.4% | 151.4% | 49.5% | · | 27.1% | 27.0% | 27.4% | · | 28.5% | 22.0% | 13.8% | · | 12.5% | |
| ROIC | -59.7% | -51.4% | · | -68.8% | -108.5% | -133.3% | · | 109.5% | 64.6% | 43.0% | · | 33.8% | 33.2% | 30.0% | · | 46.5% |
Liquidez y Solvencia
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.5 | 1.4 | · | 1.4 | 1.4 | 1.3 | · | 1.4 | 1.2 | 1.4 | · | 1.2 | 1.2 | 1.2 | · | 1.3 | |
| Quick Ratio | 1.1 | 1.1 | · | 1.0 | 1.1 | 1.0 | · | 1.1 | 0.9 | 1.1 | · | 1.0 | 1.0 | 0.9 | · | 1.0 |
Eficiencia
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.2 | 0.2 | · | 0.2 | 0.2 | 0.2 | · | 0.2 | 0.2 | 0.2 | · | 0.2 | 0.2 | 0.2 | · | 0.2 | |
| Receivables Turnover | 1.4 | 1.4 | · | 1.5 | 1.4 | 1.3 | · | 1.5 | 1.5 | 1.3 | · | 1.5 | 1.5 | 1.4 | · | 1.4 |
Por Acción
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $-11.96 | $-10.92 | · | $-8.06 | $-4.98 | $-3.46 | · | $4.68 | $7.44 | $10.31 | · | $13.13 | $11.15 | $9.11 | · | $5.91 | |
| Revenue / Share | $53.77 | $49.59 | · | $46.36 | $43.68 | $39.66 | · | $38.04 | $35.83 | $33.91 | · | $33.19 | $32.12 | $31.06 | · | $31.62 | |
| Cash Flow / Share | · | $4.66 | · | · | · | $2.21 | · | · | · | $-1.49 | · | · | · | $5.00 | · | · | |
| Cash / Share | $10.46 | $9.31 | · | $9.95 | $9.55 | $5.68 | · | $12.96 | $4.90 | $3.84 | · | $4.92 | $3.59 | $3.50 | · | $4.08 | |
| EPS (TTM) | $12.15 | $10.71 | · | $9.70 | $10.16 | $10.08 | · | $9.29 | $9.41 | $8.82 | · | $6.59 | $5.10 | $5.49 | · | $6.85 |
Valoración (TTM)
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $14.01B | $13.84B | · | $13.32B | $13.16B | $12.97B | · | $12.67B | $12.52B | $12.34B | · | $11.91B | $11.74B | $11.67B | · | $11.64B | |
| Net Income TTM | $847M | $781M | · | $772M | $836M | $860M | · | $828M | $860M | $816M | · | $609M | $468M | $514M | · | $680M | |
| Market Cap | $14.23B | $10.63B | · | $9.43B | $10.57B | $11.82B | · | $13.54B | $11.79B | $12.40B | · | $8.64B | $9.17B | $7.35B | · | $7.46B | |
| P/E | 18.3 | 14.4 | · | 13.7 | 14.0 | 15.2 | · | 17.6 | 14.7 | 15.7 | · | 14.3 | 19.7 | 14.8 | · | 12.1 | |
| P/S | 1.0 | 0.8 | · | 0.7 | 0.8 | 0.9 | · | 1.1 | 0.9 | 1.0 | · | 0.7 | 0.8 | 0.6 | · | 0.6 | |
| P/B | -18.6 | -14.1 | · | -16.5 | -28.6 | -44.3 | · | 35.0 | 18.6 | 13.4 | · | 7.2 | 9.0 | 8.9 | · | 14.0 | |
| P / Cash Flow | · | 33.1 | · | · | · | 65.7 | · | · | · | -92.0 | · | · | · | 15.9 | · | · | |
| Earnings Yield | 5.5% | 7.0% | · | 7.3% | 7.1% | 6.6% | · | 5.7% | 6.8% | 6.4% | · | 7.0% | 5.1% | 6.8% | · | 8.3% |
Período más reciente a la izquierda · valores nulos mostrados como ·
Estados Financieros Estado de resultados, balance general, flujo de caja — anual, últimos 5 años
| Métrica | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Ingresos | $13.64B | $12.82B | $12.14B | $11.61B | $11.62B |
| Margen Operativo % | 15.0% | 16.3% | 13.2% | 11.5% | 15.5% |
| Beneficio neto | $747M | $936M | $692M | $560M | $978M |
| EPS Diluido | $9.84 | $10.73 | $7.42 | $5.85 | $8.90 |
| Métrica | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Ratio corriente | 1.3 | 1.3 | 1.2 | 1.2 | 1.3 |
| Ratio Rápido | 1.0 | 1.0 | 0.9 | 0.9 | 1.0 |
| Métrica | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Flujo de caja libre | $1.31B | $1.47B | $1.49B | $961M | $1.29B |
Propietarios institucionales (13F) 694 declarantes · $13.6B total · A fecha de 30 de septiembre de 2026
Instituciones que informan tener esta acción en su Formulario 13F trimestral de la SEC. Solo posiciones largas; un solo presentador puede aparecer dos veces para tramos de opciones separados. Las patas de put/call de compensación grandes suelen reflejar la creación de mercado o el inventario cubierto, no la convicción direccional.
| Nuevas posiciones | Posiciones cerradas | Aumentado | Disminuido | Cambio neto de acciones |
|---|---|---|---|---|
| 126 (-14 vs trimestre anterior) | 61 (-2 vs trimestre anterior) | 195 (+23 vs trimestre anterior) | 226 (+12 vs trimestre anterior) | -1.1M |
Comparado con Q1 2026. Las presentaciones del Formulario 13F de la SEC vencen dentro de los 45 días posteriores al final del trimestre, más un pequeño margen para los presentadores tardíos; los trimestres que aún se encuentran dentro de esa ventana se omiten en favor del par más reciente completamente reportado.
| Institución | Valor | Acciones | % de 13F rastreadas | Tipo |
|---|---|---|---|---|
| Berkshire Hathaway Inc | $6 425 268 898 | 28 880 209 | 47,23% | Acciones |
| BlackRock, Inc. | $547 520 494 | 2 460 987 | 4,02% | Acciones |
| VANGUARD GROUP INC | $471 976 159 | 4 154 354 | 3,47% | Acciones |
| VANGUARD CAPITAL MANAGEMENT LLC | $467 525 034 | 2 101 425 | 3,44% | Acciones |
| MORGAN STANLEY | $356 348 822 | 1 601 710 | 2,62% | Acciones |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $306 558 307 | 1 377 914 | 2,25% | Acciones |
| STATE STREET CORP | $294 345 267 | 1 323 019 | 2,16% | Acciones |
| Invesco Ltd. | $269 627 293 | 1 211 917 | 1,98% | Acciones |
| DIMENSIONAL FUND ADVISORS LP | $253 130 449 | 1 137 814 | 1,86% | Acciones |
| NEUBERGER BERMAN GROUP LLC | $205 758 498 | 925 579 | 1,51% | Acciones |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | $197 802 963 | 889 082 | 1,45% | Acciones |
| GEODE CAPITAL MANAGEMENT, LLC | $189 562 167 | 853 602 | 1,39% | Acciones |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $163 166 832 | 733 400 | 1,20% | Opción de compra |
| Gates Capital Management, Inc. | $153 096 497 | 688 136 | 1,13% | Acciones |
| BANK OF AMERICA CORP /DE/ | $145 056 737 | 651 999 | 1,07% | Acciones |
| D. E. Shaw & Co., Inc. | $142 571 191 | 640 827 | 1,05% | Acciones |
| AQR CAPITAL MANAGEMENT LLC | $128 131 338 | 587 758 | 0,94% | Acciones |
| GOLDMAN SACHS GROUP INC | $103 093 004 | 463 381 | 0,76% | Acciones |
| Bank of New York Mellon Corp | $101 127 189 | 454 545 | 0,74% | Acciones |
| NORDEA INVESTMENT MANAGEMENT AB | $87 427 043 | 395 687 | 0,64% | Acciones |
| NORTHERN TRUST CORP | $84 995 593 | 382 037 | 0,62% | Acciones |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $81 331 791 | 365 569 | 0,60% | Acciones |
| NORGES BANK | $76 627 007 | 344 422 | 0,56% | Acciones |
| UBS Group AG | $67 900 673 | 305 199 | 0,50% | Acciones |
| JANE STREET GROUP, LLC | $62 548 028 | 281 140 | 0,46% | Acciones |
| JANE STREET GROUP, LLC | $53 573 184 | 240 800 | 0,39% | Opción de compra |
| Holocene Advisors, LP | $52 875 709 | 237 665 | 0,39% | Acciones |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $48 100 176 | 216 200 | 0,35% | Opción de venta |
| ROYAL BANK OF CANADA | $47 787 000 | 214 787 | 0,35% | Acciones |
| DEUTSCHE BANK AG\ | $46 356 378 | 208 362 | 0,34% | Acciones |
| Quantinno Capital Management LP | $45 366 106 | 203 910 | 0,33% | Acciones |
| JPMORGAN CHASE & CO | $44 467 785 | 200 781 | 0,33% | Acciones |
| CITADEL ADVISORS LLC | $44 465 298 | 199 862 | 0,33% | Acciones |
| CITADEL ADVISORS LLC | $44 184 528 | 198 600 | 0,32% | Opción de compra |
| BARCLAYS PLC | $43 410 740 | 195 122 | 0,32% | Acciones |
| VANGUARD FIDUCIARY TRUST CO | $40 134 502 | 180 396 | 0,29% | Acciones |
| WEDGE CAPITAL MANAGEMENT L L P/NC | $37 089 700 | 241 328 | 0,27% | Acciones |
| Gotham Asset Management, LLC | $36 393 278 | 163 580 | 0,27% | Acciones |
| JANE STREET GROUP, LLC | $35 774 784 | 160 800 | 0,26% | Opción de venta |
| Doma Perpetual Capital Management LLC | $35 522 937 | 159 668 | 0,26% | Acciones |
| FIRST TRUST ADVISORS LP | $34 161 205 | 153 548 | 0,25% | Acciones |
| TODD ASSET MANAGEMENT LLC | $32 697 663 | 146 969 | 0,24% | Acciones |
| LOS ANGELES CAPITAL MANAGEMENT LLC | $32 011 312 | 143 884 | 0,24% | Acciones |
| Allianz Asset Management GmbH | $30 236 367 | 135 906 | 0,22% | Acciones |
| Toroso Investments, LLC | $29 297 520 | 257 878 | 0,22% | Acciones |
| CANADA PENSION PLAN INVESTMENT BOARD | $26 480 460 | 119 024 | 0,19% | Acciones |
| VICTORY CAPITAL MANAGEMENT INC | $26 377 896 | 118 563 | 0,19% | Acciones |
| Amundi | $25 967 198 | 116 717 | 0,19% | Acciones |
| FMR LLC | $25 475 535 | 114 507 | 0,19% | Acciones |
| Davidson Kempner Capital Management LP | $25 162 043 | 113 098 | 0,18% | Acciones |
Activistas y propietarios del %+ 5 1 tenencia
Inversores que presentaron el Anexo 13D de la SEC — propiedad beneficiosa superior al % 5 con la intención de influir en el emisor (participaciones activistas, campañas de la junta directiva, M&A). Cada fila muestra el estado conocido más reciente de la posición de ese declarante.
| Declarante | Presentado | Participación | Estado | Propósito | Presentación |
|---|---|---|---|---|---|
| Warren E. Buffett, Berkshire Hathaway Inc., National Indemnity Company, GEICO Corporation, Government Employees Insurance Company, Berkshire Hathaway Consolidated Pension Plan Master Trust, BNSF Master Retirement Trust, Scott Fetzer Company Collective Investment Trust, R. Ted Weschler ×13 presentaciones | 13 de febrero de 2025 | 45,00% | Enmienda | · | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Informantes de la empresa 59 insiders · 31 directivos · 25 consejeros
| Insider | Rol | Última actividad | Acciones en propiedad | Compras 12m | Ventas 12m | Neto 12m |
|---|---|---|---|---|---|---|
| Javier Rodriguez | Chief Executive Officer | 16 de junio de 2026 S | 840 408 | 0 | 2 | $-14 532 097 |
| Dennis Kogod | Pres, HCP & CEO, DVA Int. | 17 de mayo de 2016 S | 18 766 | 0 | 0 | $0 |
| Joel Ackerman | CFO and Treasurer | 7 de mayo de 2026 S | 132 434 | 0 | 1 | $-9 887 579 |
| Luis Borgen | Chief Financial Officer | 22 de marzo de 2012 M | 18 517 | 0 | 0 | $0 |
| Richard K Whitney | Chief Financial Officer | 31 de marzo de 2010 A | 33 604 | 0 | 0 | $0 |
| Mark G Harrison | Chief Financial Officer | 14 de marzo de 2007 A | 31 250 | 0 | 0 | $0 |
| Gary Beil | Acting Chief Financial Officer | 1 de julio de 2006 A | 10 000 | 0 | 0 | $0 |
| David Paul Maughan | Chief Operating Officer, DKC | 22 de septiembre de 2026 F | 86 604 | 0 | 2 | $-4 089 696 |
| Michael David Staffieri | Chief Operating Officer, DKC | 16 de agosto de 2024 S | 209 365 | 0 | 0 | $0 |
| Joseph C Mello | COO, HCP | 24 de diciembre de 2016 A | 4 688 | 0 | 0 | $0 |
| Kathleen Alyce Waters | Chief Legal & Pub. Affairs Off | 15 de junio de 2026 S | 109 194 | 0 | 2 | $-3 210 360 |
| James O Hearty | Chief Compliance Officer | 14 de mayo de 2026 M | 22 389 | 0 | 2 | $-3 291 616 |
| Christopher Michael Berry | Chief Accounting Officer | 15 de marzo de 2026 A | 19 640 | 0 | 0 | $0 |
| John D Winstel | Chief Accounting Officer | 15 de marzo de 2023 F | 15 676 | 0 | 0 | $0 |
| Leanne M Zumwalt | Group VP, Government Affairs | 18 de septiembre de 2020 M | 24 590 | 0 | 0 | $0 |
| Kent J Thiry | Executive Chairman | 1 de junio de 2020 F | 110 462 | 0 | 0 | $0 |
| James K Hilger | Chief Accounting Officer | 2 de junio de 2019 F | 33 125 | 0 | 0 | $0 |
| Jeanine Marie Jiganti | Chief Compliance Officer | 13 de junio de 2017 M | 3 514 | 0 | 0 | $0 |
| Kim M Rivera | Chief Legal Officer | 22 de septiembre de 2015 M | 7 438 | 0 | 0 | $0 |
| Robert J Margolis | Co-Chairman of the Board | 4 de junio de 2015 S | 2 322 928 | 0 | 0 | $0 |
| Allen Nissenson | Chief Medical Officer | 13 de febrero de 2014 M | 8 990 | 0 | 0 | $0 |
| Garry E Menzel | Senior Vice President, Finance | 9 de septiembre de 2013 A | · | 0 | 0 | $0 |
| David T Shapiro | Chief Special Counsel | 2 de agosto de 2013 G | 2 315 | 0 | 0 | $0 |
| Thomas O Usilton | Senior Vice President | 29 de febrero de 2012 M | 17 491 | 0 | 0 | $0 |
| Georgina Randolph | Senior Vice President | 17 de junio de 2009 M | 5 547 | 0 | 0 | $0 |
| Joseph Schohl | VP, Gen. Counsel & Secretary | 13 de febrero de 2009 M | 2 084 | 0 | 0 | $0 |
| Christopher J Riopelle | Chief Compliance Officer | 11 de agosto de 2008 M | 2 500 | 0 | 0 | $0 |
| Mary Kowenhoven | Vice President - Strategy | 5 de marzo de 2008 A | · | 0 | 0 | $0 |
| Patricia Jones | Chief People Officer | 16 de julio de 2007 A | 6 250 | 0 | 0 | $0 |
| Charles J Mcallister | Chief Medical Officer | 8 de mayo de 2007 M | 999 | 0 | 0 | $0 |
| Thomas L Kelly | Executive Vice President | 4 de noviembre de 2005 M | 42 000 | 0 | 0 | $0 |
| Dennis W Pullin | Consejero | 15 de agosto de 2026 A | 2 949 | 0 | 0 | $0 |
| Gregory J. Moore | Consejero | 15 de agosto de 2026 A | 8 091 | 0 | 0 | $0 |
| Jason M. Hollar | Consejero | 15 de agosto de 2026 A | 6 883 | 0 | 0 | $0 |
| Patricia M Arway | Consejero | 15 de agosto de 2026 A | 27 223 | 0 | 0 | $0 |
| Adam H Schechter | Consejero | 15 de agosto de 2026 A | 5 970 | 0 | 0 | $0 |
| Wendy Lee Schoppert | Consejero | 15 de agosto de 2026 A | 278 | 0 | 0 | $0 |
| Phyllis R Yale | Consejero | 15 de agosto de 2026 A | 9 803 | 0 | 0 | $0 |
| Barbara J Desoer | Consejero | 15 de agosto de 2026 A | 278 | 0 | 0 | $0 |
| Charles Berg | Consejero | 15 de mayo de 2025 A | 19 982 | 0 | 0 | $0 |
| John M Nehra | Consejero | 15 de mayo de 2024 A | 363 | 0 | 0 | $0 |
| Paul J Diaz | Consejero | 15 de mayo de 2023 A | 16 069 | 0 | 0 | $0 |
| Paula A Price | Consejero | 15 de mayo de 2022 A | 1 395 | 0 | 0 | $0 |
| Shawn M Guertin | Consejero | 15 de mayo de 2021 A | 1 105 | 0 | 0 | $0 |
| Pascal Desroches | Consejero | 15 de noviembre de 2020 A | 8 030 | 0 | 0 | $0 |
| William L Roper | Consejero | 11 de junio de 2020 A | 16 234 | 0 | 0 | $0 |
| Peter T Grauer | Consejero | 11 de junio de 2020 A | 76 204 | 0 | 0 | $0 |
| Carol Anthony Davidson | Consejero | 31 de diciembre de 2017 A | 10 764 | 0 | 0 | $0 |
| Willard Woodson Brittain JR | Consejero | 11 de junio de 2012 A | 7 195 | 0 | 0 | $0 |
| Richard C Vaughan | Consejero | 13 de mayo de 2010 A | 6 092 | 0 | 0 | $0 |
| Nancy Ann Deparle | Consejero | 30 de junio de 2008 A | 3 256 | 0 | 0 | $0 |
| Raymond C Larkin JR | Consejero | 31 de marzo de 2007 A | 8 684 | 0 | 0 | $0 |
| Michele J Hooper | Consejero | 13 de mayo de 2005 A | 680 | 0 | 0 | $0 |
| R. Ted Weschler | · | 17 de septiembre de 2020 S | 1 991 806 | 0 | 0 | $0 |
| Roger Valine | · | 30 de junio de 2017 A | 306 | 0 | 0 | $0 |
| Laura Mildenberger | · | 17 de diciembre de 2015 M | 8 447 | 0 | 0 | $0 |
| Richard B Fontaine | · | 16 de mayo de 2007 G | 10 000 | 0 | 0 | $0 |
| Lori Richardson Pelliccioni | · | 25 de febrero de 2005 M | 3 000 | 0 | 0 | $0 |
| Patrick A Broderick | · | 5 de mayo de 2004 M | 0 | 0 | 0 | $0 |
Informantes de las presentaciones SEC Form 3/4/5; neto = solo P/S de mercado abierto
Propiedad de ETFs Mantenido por 97 ETFs
El peso refleja solo las tenencias directas de acciones (N-PORT); los fondos apalancados o basados en derivados pueden tener exposición adicional a swaps no mostrada.
| Fondo | Ponderación | Unidades | A fecha de | Fuente |
|---|---|---|---|---|
| OMAH · Tidal Trust III | 5,19% | 213 947 NS | 31 de julio de 2026 | N-PORT |
| STNC · Hennessy Funds Trust | 3,36% | 13 006 NS | 31 de julio de 2026 | N-PORT |
| AZTD · Tidal Trust I | 3,06% | 4 824 NS | 31 de julio de 2026 | N-PORT |
| FXH · First Trust Exchange-Traded AlphaDE… | 2,44% | 106 663 NS | 31 de julio de 2026 | N-PORT |
| RSPH · Invesco Exchange-Traded Fund Trust | 1,56% | 77 933 SH | 1 de octubre de 2026 | Diario |
| AMOM · Exchange Listed Funds Trust | 1,41% | 1 399 NS | 31 de julio de 2026 | N-PORT |
| LSEQ · Harbor ETF Trust | 1,19% | 760 NS | 31 de julio de 2026 | N-PORT |
| IHF · iShares Trust | 0,85% | 61 700 SH | 11 de septiembre de 2026 | Diario |
| JMID · Janus Detroit Street Trust | 0,46% | 456 NS | 31 de julio de 2026 | N-PORT |
| JPME · J.P. Morgan Exchange-Traded Fund Tr… | 0,46% | 8 917 NS | 31 de julio de 2026 | N-PORT |
| IQSM · New York Life Investments ETF Trust | 0,34% | 4 688 NS | 31 de julio de 2026 | N-PORT |
| JPUS · J.P. Morgan Exchange-Traded Fund Tr… | 0,34% | 6 488 NS | 31 de julio de 2026 | N-PORT |
| VFMF · VANGUARD WELLINGTON FUND | 0,31% | 9 914 SH | 19 de agosto de 2026 | Diario |
| ROSC · Lattice Strategies Trust | 0,27% | 691 NS | 31 de julio de 2026 | N-PORT |
| PKW · Invesco Exchange-Traded Fund Trust | 0,24% | 22 551 SH | 1 de octubre de 2026 | Diario |
| BKMC · BNY Mellon ETF Trust | 0,22% | 5 948 NS | 31 de julio de 2026 | N-PORT |
| DFAS · Dimensional ETF Trust | 0,20% | 126 925 NS | 31 de julio de 2026 | N-PORT |
| RSP · Invesco Exchange-Traded Fund Trust | 0,20% | 1 068 917 SH | 1 de octubre de 2026 | Diario |
| BBMC · J.P. Morgan Exchange-Traded Fund Tr… | 0,18% | 15 260 NS | 31 de julio de 2026 | N-PORT |
| FNK · First Trust Exchange-Traded AlphaDE… | 0,15% | 1 456 NS | 31 de julio de 2026 | N-PORT |
| VBR · VANGUARD INDEX FUNDS | 0,15% | 467 367 SH | 19 de agosto de 2026 | Diario |
| FHLC · FIDELITY COVINGTON TRUST | 0,12% | 15 871 NS | 31 de julio de 2026 | N-PORT |
| ISCG · iShares Trust | 0,12% | 6 102 SH | 11 de septiembre de 2026 | Diario |
| VHT · VANGUARD WORLD FUND | 0,11% | 100 394 SH | 19 de agosto de 2026 | Diario |
| ESML · iShares Trust | 0,10% | 16 178 SH | 11 de septiembre de 2026 | Diario |
| IYH · iShares Trust | 0,09% | 18 805 SH | 11 de septiembre de 2026 | Diario |
| EQAL · Invesco Exchange-Traded Fund Trust … | 0,09% | 4 161 SH | 1 de octubre de 2026 | Diario |
| VB · VANGUARD INDEX FUNDS | 0,09% | 736 199 SH | 19 de agosto de 2026 | Diario |
| CURE · Direxion Shares ETF Trust | 0,09% | 632 NS | 31 de julio de 2026 | N-PORT |
| SMMD · iShares Trust | 0,08% | 17 274 SH | 11 de septiembre de 2026 | Diario |
| FNX · First Trust Exchange-Traded AlphaDE… | 0,08% | 4 629 NS | 31 de julio de 2026 | N-PORT |
| TILT · FlexShares Trust | 0,08% | 7 288 NS | 31 de julio de 2026 | N-PORT |
| IXJ · iShares Trust | 0,07% | 16 934 SH | 11 de septiembre de 2026 | Diario |
| RWL · Invesco Exchange-Traded Fund Trust … | 0,07% | 38 169 SH | 1 de octubre de 2026 | Diario |
| DFAC · Dimensional ETF Trust | 0,06% | 121 442 NS | 31 de julio de 2026 | N-PORT |
| IUS · Invesco Exchange-Traded Self-Indexe… | 0,06% | 3 244 SH | 1 de octubre de 2026 | Diario |
| DUHP · Dimensional ETF Trust | 0,06% | 29 605 NS | 31 de julio de 2026 | N-PORT |
| WSML · iShares Trust | 0,05% | 2 005 SH | 10 de septiembre de 2026 | Diario |
| IWS · iShares Trust | 0,05% | 45 297 SH | 11 de septiembre de 2026 | Diario |
| FAB · First Trust Exchange-Traded AlphaDE… | 0,05% | 322 NS | 31 de julio de 2026 | N-PORT |
| IWR · iShares Trust | 0,04% | 131 978 SH | 11 de septiembre de 2026 | Diario |
| DCOR · Dimensional ETF Trust | 0,04% | 5 974 NS | 31 de julio de 2026 | N-PORT |
| CATH · Global X Funds | 0,04% | 1 967 NS | 31 de julio de 2026 | N-PORT |
| XOEF · iShares Trust | 0,04% | 43 SH | 10 de septiembre de 2026 | Diario |
| PRF · Invesco Exchange-Traded Fund Trust | 0,03% | 15 586 SH | 1 de octubre de 2026 | Diario |
| SPMO · Invesco Exchange-Traded Fund Trust … | 0,03% | 34 392 SH | 1 de octubre de 2026 | Diario |
| DFAU · Dimensional ETF Trust | 0,03% | 13 203 NS | 31 de julio de 2026 | N-PORT |
| CHRI · Global X Funds | 0,02% | 8 NS | 31 de julio de 2026 | N-PORT |
| DFSU · Dimensional ETF Trust | 0,02% | 2 124 NS | 31 de julio de 2026 | N-PORT |
| EGLE · Global X Funds | 0,02% | 2 NS | 31 de julio de 2026 | N-PORT |
| VOOV · VANGUARD ADMIRAL FUNDS | 0,02% | 7 420 SH | 19 de agosto de 2026 | Diario |
| VONV · VANGUARD SCOTTSDALE FUNDS | 0,02% | 18 428 SH | 19 de agosto de 2026 | Diario |
| IVE · iShares Trust | 0,02% | 53 283 SH | 11 de septiembre de 2026 | Diario |
| IUSV · iShares Trust | 0,02% | 27 948 SH | 11 de septiembre de 2026 | Diario |
| NEAR · iShares U.S. ETF Trust | 0,02% | 949 000 SH | 9 de septiembre de 2026 | Diario |
| DSI · iShares Trust | 0,02% | 4 810 SH | 11 de septiembre de 2026 | Diario |
| IWD · iShares Trust | 0,01% | 67 699 SH | 11 de septiembre de 2026 | Diario |
| XRMI · Global X Funds | 0,01% | 30 NS | 31 de julio de 2026 | N-PORT |
| XYLD · Global X Funds | 0,01% | 1 746 NS | 31 de julio de 2026 | N-PORT |
| PTLC · Pacer Funds Trust | 0,01% | 1 706 NS | 31 de julio de 2026 | N-PORT |
| DYNF · BlackRock ETF Trust | 0,01% | 27 844 SH | 11 de septiembre de 2026 | Diario |
| XYLG · Global X Funds | 0,01% | 32 NS | 31 de julio de 2026 | N-PORT |
| SPUU · Direxion Shares ETF Trust | 0,01% | 121 NS | 31 de julio de 2026 | N-PORT |
| DFUS · Dimensional ETF Trust | 0,01% | 9 492 NS | 31 de julio de 2026 | N-PORT |
| QDPL · Pacer Funds Trust | 0,01% | 766 NS | 31 de julio de 2026 | N-PORT |
| TOPC · iShares Trust | 0,01% | 19 SH | 10 de septiembre de 2026 | Diario |
| XVV · iShares Trust | 0,01% | 377 SH | 10 de septiembre de 2026 | Diario |
| VOO · VANGUARD INDEX FUNDS | 0,01% | 832 243 SH | 19 de agosto de 2026 | Diario |
| VTI · VANGUARD INDEX FUNDS | 0,01% | 1 019 458 SH | 19 de agosto de 2026 | Diario |
| VT · VANGUARD INTERNATIONAL EQUITY INDEX… | 0,01% | 28 136 SH | 19 de agosto de 2026 | Diario |
| VONE · VANGUARD SCOTTSDALE FUNDS | 0,01% | 5 315 SH | 19 de agosto de 2026 | Diario |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,01% | 2 714 SH | 19 de agosto de 2026 | Diario |
| ESGV · VANGUARD WORLD FUND | 0,01% | 7 283 SH | 19 de agosto de 2026 | Diario |
| XTR · Global X Funds | 0,01% | 2 NS | 31 de julio de 2026 | N-PORT |
| HCMT · Direxion Shares ETF Trust | 0,01% | 225 NS | 31 de julio de 2026 | N-PORT |
| IWP · iShares Trust | 0,01% | 9 703 SH | 11 de septiembre de 2026 | Diario |
| PBP · Invesco Exchange-Traded Fund Trust | 0,01% | 203 SH | 30 de septiembre de 2026 | Diario |
| SPXL · Direxion Shares ETF Trust | 0,01% | 2 512 NS | 31 de julio de 2026 | N-PORT |
| IVV · iShares Trust | 0,01% | 404 382 SH | 11 de septiembre de 2026 | Diario |
| IWB · iShares Trust | 0,01% | 22 249 SH | 11 de septiembre de 2026 | Diario |
| IYY · iShares Trust | 0,01% | 1 374 SH | 10 de septiembre de 2026 | Diario |
| IWV · iShares Trust | 0,01% | 8 841 SH | 10 de septiembre de 2026 | Diario |
| ITOT · iShares Trust | 0,01% | 41 624 SH | 11 de septiembre de 2026 | Diario |
| PHDG · Invesco Actively Managed Exchange-T… | 0,01% | 24 SH | 30 de septiembre de 2026 | Diario |
| XCLR · Global X Funds | 0,01% | 1 NS | 31 de julio de 2026 | N-PORT |
| OMFL · Invesco Exchange-Traded Self-Indexe… | 0,01% | 1 542 SH | 1 de octubre de 2026 | Diario |
| IWF · iShares Trust | 0,00% | 6 443 SH | 2 de septiembre de 2026 | Diario |
| GTO · Invesco Actively Managed Exchange-T… | 0,00% | 7 000 | 30 de septiembre de 2026 | Diario |
| VONG · VANGUARD SCOTTSDALE FUNDS | 0,00% | 2 838 SH | 19 de agosto de 2026 | Diario |
| VGHY · VANGUARD FIXED INCOME SECURITIES FU… | · | · | 15 de julio de 2026 | Diario |
| VCRB · VANGUARD MALVERN FUNDS | · | · | 15 de julio de 2026 | Diario |
| VPLS · VANGUARD MALVERN FUNDS | · | · | 15 de julio de 2026 | Diario |
| VGMS · VANGUARD MALVERN FUNDS | · | · | 15 de julio de 2026 | Diario |
| ISCB · iShares Trust | · | 1 571 SH | 11 de septiembre de 2026 | Diario |
| ISCV · iShares Trust | · | 3 661 SH | 11 de septiembre de 2026 | Diario |
| SMLF · iShares Trust | · | 5 973 SH | 11 de septiembre de 2026 | Diario |
| SMMV · iShares Trust | · | 1 837 SH | 1 de septiembre de 2026 | Diario |
DVA Consenso de analistas Opiniones de analistas alcistas y bajistas, precio objetivo a 12 meses, potencial alcista
Precio objetivo a 12 meses
7 analistas · 2026-09-27Objetivo medio $219.86 +23,0%
Comparación de pares (subindustria GICS) Métricas clave frente a competidores del sector
Base del ejercicio fiscal, precios al cierre del último ejercicio fiscal de cada empresa.
| Ticker | Capitalización Bursátil | P/E | Ingresos interanuales | Margen Neto | ROE | Margen Bruto |
|---|---|---|---|---|---|---|
| DVA | $7.79B | 11.5 | 6.5% | 5.5% | -281.8% | · |
| DGX | $19.09B | 19.8 | 11.8% | 9.0% | 14.2% | · |
| LH | $20.62B | 24.0 | 7.2% | 6.3% | 10.3% | 28.8% |
| GH | $13.34B | -30.8 | 32.9% | -42.4% | 205.7% | · |
| LH | $20.62B | 24.0 | 7.2% | 6.3% | 10.3% | 28.8% |
| BTSG | $7.20B | 43.0 | 28.2% | 1.5% | 10.8% | 11.8% |
| HNGE | $0 | -6.0 | 50.6% | -89.9% | -299.8% | 79.7% |
| HIMS | · | 63.7 | 59.0% | 5.5% | 23.3% | 73.8% |
| CHE | · | 23.3 | 4.1% | 10.5% | 24.4% | · |
| RDNT | $5.28B | -285.4 | 11.5% | -0.91% | -1.9% | · |
| CVS | $100.87B | 57.1 | 7.8% | 0.44% | 2.4% | · |
Señales de trading Señales recientes de compra/venta con precio de entrada y ratio riesgo/recompensa
Ninguna señal abierta en este momento — ninguna tarjeta está completada, y eso es honesto.
Mis Métricas Tu lista de seguimiento personal — filas seleccionadas de Fundamentales Completos
Seleccione las métricas que le importan: haga clic en el + junto a cualquier fila en Fundamentales completos arriba.
Tu selección se guarda y te sigue en todos los tickers.